Endothelial dysfunction and atherosclerosis related miRNA-expression in patients with haemophilia

Haemophilia. 2023 Jan;29(1):61-71. doi: 10.1111/hae.14658. Epub 2022 Sep 16.

Abstract

Introduction: Elevated markers of endothelial dysfunction and inflammation indicate worse endothelial function in the aging haemophilia population. MicroRNAs (miRNAs) regulate gene expression post-transcriptionally. Several miRNAs have been shown to be involved in the process of endothelial dysfunction and atherosclerosis.

Aim: The aim of this study was to determine the underlying molecular pathways of endothelial dysfunction and inflammation in haemophilia patients.

Methods: A total of 25 patients with severe or moderate haemophilia A (20 patients) or B (5 patients), 14 controls and 18 patients with coronary artery disease (CAD) after myocardial infarction were included in this study. Expression of miRNA-126, -155, -222, -1, -let7a, -21 and -197 were analysed using a real time polymerase chain reaction. Network-based visualisation and analysis of the miRNA-target interactions were performed using the MicroRNA ENrichment TURned NETwork (MIENTURNET).

Results: Expression of miRNA-126 (p < .05) and miRNA-let7a (p < .05) were significantly higher in CAD patients compared to haemophilia patients and controls. MiRNA-21 (p < .05) was significantly elevated in CAD patients compared to controls. MiRNA-155 (p < .05), miRNA-1 (p < .05) and miRNA-197 (p < .05) were significantly higher expressed in CAD and haemophilia patients compared to controls and showed a strong correlation with increased levels of interleukin-6 (IL-6) and soluble intercellular adhesion molecule-1 (sICAM-1). The network analysis revealed interactions in the cytokine signalling, focal adhesion and VEGFA-VEGFR2 pathway (Vascular endothelial growth factor, -receptor).

Conclusion: This study characterises miRNA expression in haemophilia patients in comparison to CAD patients and healthy controls. The results imply comparable biological processes in CAD and haemophilia patients.

Keywords: atherosclerosis; comorbidity; coronary artery disease; endothelial dysfunction; haemophilia; miRNA.

MeSH terms

  • Atherosclerosis* / genetics
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / genetics
  • Hemophilia A* / complications
  • Hemophilia A* / genetics
  • Humans
  • Inflammation
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Vascular Endothelial Growth Factor A

Substances

  • MicroRNAs
  • Vascular Endothelial Growth Factor A
  • MIRN126 microRNA, human
  • MIRN155 microRNA, human

Grants and funding